Chikungunya Virus-Like Particles as Vaccine Candidates: A Pilot Study

Kirjan Chikungunya Virus-Like Particles as Vaccine Candidates: A Pilot Study (2022) on kirjoittanut Shweta Saraswat. Kirjan kieli on englanti, ja sen on kustantanut Delve Publishing. Kirja on laajuudeltaan 187 sivua ja se on sidottu.

Chikungunya Virus VLP (Virus-Like Particle) is a unique product that has been developed in response to the need for high purity, properly assembled and glycosylated Chikungunya virus antigens for use in the development of Chikungunya virus diagnostics and in vaccine development and R&D. This book presents main emphasis continues to be the Chikungunya virus for virology interests, although they have been described in specific cases where more is known about the mechanism of Chikungunya virus replication. The chapters have been organized in such a way that they provide sequential knowledge. Chikungunya virus (CHIKV) has now emerged as one of the most important arbovirus of public health significance. Infection of CHIKV in humans is characterized by rash, high fever and severe arthritis that may persist for years.